Molecular dissection of the interaction between HIC1 and SIRT1

Biochemical and Biophysical Research Communications

Volumn 421, Issue 2, 2012, Pages 384-388

  Dehennaut, Vanessa ^a,b   Loison, Ingrid ^a   Pinte, Sébastien ^a   Leprince, Dominique ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Acetylation; HIC1; SIRT1

Indexed keywords

PROTEIN; PROTEIN HIC1; SIRTUIN 1; UNCLASSIFIED DRUG;

ARTICLE; DNA DAMAGE; GENOTOXICITY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SUMOYLATION; ZINC FINGER MOTIF;

ACETYLATION; DNA DAMAGE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROTEIN INTERACTION DOMAINS AND MOTIFS; SERINE; SIRTUIN 1; SUMOYLATION; ZINC FINGERS;

EID: 84860439957     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.026     Document Type: Article

References (24)

1. Wales M.M., Biel M.A., el Deiry W., Nelkin B.D., Issa J.P., Cavenee W.K., Kuerbitz S.J., Baylin S.B. P53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1995, 1:570-577.
2. Fleuriel C., Touka M., Boulay G., Guérardel C., Rood B.R., Leprince D. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. Int. J. Biochem. Cell Biol. J. 2009, 41:26-33.
3. Pinte S., Stankovic-Valentin N., Deltour S., Rood B.R., Guerardel C., Leprince D. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J. Biol. Chem. 2004, 279:38313-38324.
4. Chen W.Y., Wang D.H., Yen R.C., Luo J., Gu W., Baylin S.B. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005, 123:437-448.
5. Zhang Q., Wang S.Y., Fleuriel C., Leprince D., Rocheleau J.V., Piston D.W., Goodman R.H. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl. Acad. Sci. USA 2007, 16:829-833.
6. Van Rechem C., Boulay G., Pinte S., Stankovic-Valentin N., Guerardel C., Leprince D. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol. Cell. Biol. 2010, 30:4045-4059.
7. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273:793-798.
8. Zhang T., Kraus W.L. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim. Biophys. Acta 1804, 2010:1666-1675.
9. Stankovic-Valentin N., Deltour S., Seeler J., Pinte S., Vergoten G., Guerardel C., Dejean A., Leprince D. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 2007, 27:2661-2675.
10. Guerardel C., Deltour S., Pinte S., Monte D., Begue A., Godwin A.K., Leprince D. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 2001, 276:3078-3089.
11. Britschgi C., Rizzi M., Grob T.J., Tschan M.P., Hugli B., Reddy V.A., Andres A.C., Torbett B.E., Tobler A., Fey M.F. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 2006, 25:2030-2039.
12. Nemoto S., Fergusson M.M., Finkel T. Nutrient availability regulates SIRT1 through a forehead-dependent pathway. Science 2004, 306:2105-2108.
13. Chen W., Cooper T.K., Zahnow C.A., Overholtzer M., Zhao Z., Ladanyi M., Karp J.E., Gokgoz N., Wunder J.S., Andrulis I.L., Levine A.J., Mankowski J.L., Baylin S.B. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 2004, 6:387-398.
14. Tseng R.C., Lee C.C., Hsu H.S., Tzao C., Wang Y.C. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia 2009, 11:763-770.
15. Deltour S., Pinte S., Guerardel C., Wasylyk B., Leprince D. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 2002, 22:4890-4901.
16. Lefebvre T., Pinte S., Guérardel C., Deltour S., Martin-Soudant N., Slomianny M.C., Michalski J.C., Leprince D. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated. Eur. J. Biochem. 2004, 271:3843-3854.
17. Mascle X., Albagli O., Lemercier C. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers. Biochem. Biophys. Res. Commun. 2003, 300:391-396.
18. Choo Y., Klug A. Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage. Proc. Natl. Acad. Sci. USA 1994, 91:11163-11167.
19. +-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007, 26:5505-5520.
20. Kim J.E., Chen J., Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008, 451:583-586.
21. Zhao W., Kruse J.P., Tang Y., Jung S.Y., Qin J., Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 2008, 451:587-590.
22. Kang H., Suh J.Y., Jung Y.S., Jung J.W., Kim M.K., Chung J.H. Peptide switch is essential for Sirt1 deacetylase activity. Mol. Cell 2011, 44:203-213.
23. Kang H., Jung J.W., Kim M.K., Chung J.H. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One 2009, 4:e6611.
24. Dehennaut V., Leprince D. Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response. Bull. Cancer 2009, 96:E66-E72.